Description

CJC-1295 with DAC – Research Peptide

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic growth hormone–releasing hormone (GHRH) analog designed for advanced laboratory research in endocrine and metabolic pathways. The DAC modification extends peptide stability and activity, allowing for controlled studies of sustained GH signaling in experimental models.

In laboratory settings, CJC-1295 with DAC supports evaluation of GH release dynamics, IGF-1 receptor signaling, and pituitary-mediated peptide interactions over extended periods.

Available Research Quantities

• 2mg
• 5mg

Research Applications

• Researchers commonly study CJC-1295 with DAC for:
• Sustained GHRH receptor activation
• Growth hormone and IGF-1 pathway evaluation
• Pituitary receptor and endocrine signaling analysis
• Metabolic and anabolic research pathway studies
• Long-acting peptide pharmacokinetic modeling

Quality & Verification

Each batch is manufactured to ≥99% purity and verified using HPLC and mass spectrometry to ensure stability, consistency, and accuracy for advanced laboratory research environments.

Research Use Disclaimer

This product is intended strictly for laboratory research use only.
Not for human or veterinary consumption.
Handling is restricted to qualified professionals operating in approved research environments.